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Abstract
Background and Aim: Empirical antimicrobial therapy is frequently given in superficial bacterial folliculitis (SBF) and 
otitis externa (OE) in dogs, especially for the initial clinical presentation. Culture and subsequent antimicrobial susceptibility 
testing (AST) are generally limited to chronic cases with poor response to initial therapy. Several factors contribute to the 
failure to implement the use of AST in veterinary practice, i.e., long laboratory turnaround time or special requirements for 
sample shipping. Point-of-care (PoC) testing might reduce laboratory turnaround time and costs and the risk of emergence 
of multidrug-resistant pathogens. This study evaluated the Speed Biogram™ PoC test in canine SBF and OE compared with 
conventional methods for culture and AST.
Materials and Methods: Thirty-four canine samples were analyzed: eleven from SBF, seven from bacterial OE, four from 
mixed OE, six from Malassezia spp. OE, and six negative controls. Sensitivity (Se) and specificity (Sp) of the PoC test and 
the agreement between the PoC test and conventional methods were evaluated.
Results: Se and Sp of PoC test in discriminating between healthy and unhealthy subjects were 100% (95% confidence 
interval [CI] 87.66-100.00) and 100% (95% CI 54.1-100.0), respectively. For bacterial identification, the k value was 0.532. 
Se and Sp of PoC tests for AST were 81.73% (95% CI 72.95-88.63) and 93.10% (95% CI 88.86-96.98), respectively with a 
total good agreement between tests (mean k=0.714), but major (8/27) and very major (19/27) errors were observed in 55% 
of bacterial conventional culture-positive samples.
Conclusion: PoC test can identify dogs with SBF and OE, but AST is not sufficiently accurate. The lack of susceptibility 
testing for methicillin makes this test inappropriate for use in small animal practice.
Keywords: antimicrobial susceptibility test, dog, otitis externa, point-of-care test, superficial bacterial folliculitis.
Introduction
Superficial bacterial folliculitis (SBF) and otitis 
externa (OE) are very common in dogs and typically 
require long-term treatment. SBF is an infection con-
fined to the superficial portion of the hair follicle [1] and 
maybe secondary to local trauma, scratching, contami-
nation due to poor grooming, seborrhea, parasitic infes-
tation, hormonal factors, local irritants, or allergies [1]. 
The most frequent bacterial pathogen isolated from 
clinical canine samples [2] and the predominant agent 
of canine SBF [1] is Staphylococcus pseudintermedius 
(formerly S. intermedius). This is a commensal Gram-
positive coagulase-positive bacterium that resides on 
the mucosal and skin surfaces of healthy dogs [2,3] 
and can be an opportunistic pathogen causing a skin 
infection. Infection results from an interaction between 
genetic, environmental, immunological, predisposing, 
and primary factors [2-5]. SBF is the primary rea-
son for antimicrobial use in small animal practice [6]. 
Although less common, other Staphylococcus species, 
such as Staphylococcus aureus and Staphylococcus 
schleiferi [7] and other non-staphylococcal spe-
cies [1] including Escherichia coli, Proteus mirabilis, 
Corynebacterium spp., Bacillus spp., Pseudomonas spp., 
and Streptococcus canis can colonize and infect canine 
skin [1,8], the clinical relevance of isolation of these spe-
cies from SBF lesions is less clear [6]. OE is an inflam-
mation of the external ear canal [1]. Bacteria are classi-
fied as secondary causes of OE, and common organisms 
isolated from affected dogs include S. pseudintermedius, 
Proteus spp., Pseudomonas spp., Streptococcus spp., E. 
coli, and Klebsiella spp. [1,9-12]. Malassezia pachyder-
matis is a common yeast that contributes to OE as a sec-
ondary cause [1]. M. pachydermatis is found in 62-76% 
of infected canine ears, frequently in combination with 
Staphylococcus spp. and may result in a superinfection 
after antibiotic therapy [13-15]. The diagnoses of SBF 
and OE are based on history, clinical signs, otoscopic 
examination in case of OE, and cytological examination 
of pustular exudate or auricular discharge [6,16]. The 
cytological examination requires a good optical micro-
scope and an experienced operator.
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Empirical antimicrobial therapy is frequently 
given in cases of SBF or bacterial OE [17]. Culture and 
subsequent antimicrobial susceptibility testing (AST) 
are generally reserved for chronic cases with poor 
response to initial therapy. This trend is unfortunate 
given the current concerns regarding antimicrobial 
use and emergence of multidrug-resistant (MDR) bac-
teria in animals, including companion animals [17]. 
According to the international guidelines for anti-
microbial use in companion animal culture [18] and 
susceptibility testing should be performed on samples 
from small animals with suspected SBF or bacterial 
OE before treating with antibiotics [17]. Several fac-
tors contribute to the failure to implement this recom-
mendation in veterinary practice [19], for example, 
long laboratory turnaround time, special requirements 
for sample shipping (i.e., transport medium), and the 
monetary costs for pet owners. In-house culture is 
a possible alternative to laboratory analysis, but the 
microbiological expertise required to accurately per-
form and interpret the diagnostic tests, as well as to 
perform routine quality control and manage the bio-
hazard risks, is lacking in most in-clinic small diag-
nostic laboratories [17].
Point-of-care (PoC) testing for the bacteria and 
yeast involved in SBF and OE might reduce both turn-
around time and costs for pathogen detection and AST 
of infections. Increased AST may reduce the risk of 
emergence of MDR pathogens. As demonstrated in 
human medicine, implementation of antimicrobial 
management at the clinic level has positive conse-
quences on appropriate antimicrobial use, control of 
antimicrobial resistance and patient care [20]. A lim-
ited number of commercial PoC tests are available for 
on-site AST in veterinary clinics. Speed Biogram™ 
(Bio Veto Test, La Seyne sur Mer, France) is a PoC 
diagnostic test for small animals that simultaneously 
identifies bacteria and/or yeast on samples from skin 
and ears and the AST profile of the isolate (for bacte-
ria only) through simple color changes at 18-48 h after 
inoculation.
The aims of this clinical study were: (i) To eval-
uate the performances of the PoC Speed Biogram™ for 
the detection and identification of yeast and bacteria 
in canine SBF and OE comparing the results with con-
ventional laboratory culture; and (ii) to evaluate the 
PoC Speed Biogram™ for AST comparing the results 
with AST disk diffusion standard method.
Materials and Methods
Ethical approval and informed consent
All study procedures were performed in accor-
dance with European legislation for animal research 
(2010/63/EU). Samplings were performed as part 
of the wellness assessment for apparently healthy 
dogs (control group) or routine diagnostic purposes 
(unhealthy dogs) under informed consent of the 
owners. Therefore, according to the Guidelines of 
our Institution, a formal approval from the Ethical 
Committee was not required since samples were taken 
with informed owner consent. 
Sample selection
Privately owned dogs (n=34) examined at the 
University of Milan with SBF, bacterial, mixed or 
Malassezia spp. bilateral OE and healthy subjects 
used as negative controls were included in the study.
For SBF and bacterial OE groups, dogs with 
compatible history, presence of clinical signs related to 
SBF [6] or OE [21] and the cytological identification 
(modified Wright’s rapid stain - Quick Panoptic Kit; 
Pokler Italia) of bacteria phagocytosed by neutrophil 
granulocytes [6,22] on cytological specimens from skin 
or ear were included in the study. For Malassezia spp. 
OE group, dogs with compatible history, clinical signs 
related to OE and the cytological identification (mod-
ified Wright’s rapid stain - Quick Panoptic Kit; Pokler 
Italia) of Malassezia spp. yeast with a median count >5 
yeast per high power microscopical field (400×) on ear 
cytological specimens were included [22]. Those with 
both findings were included in the mixed OE group.
Control dogs were deemed healthy based on his-
tory, physical examination, and on the absence of neu-
trophil granulocytes, phagocytized bacteria and yeast 
<5 per high power microscopical field (400×) on ear 
and skin cytological specimens.
Dogs given local or systemic antibiotic/antimy-
cotic drugs in the previous 2 weeks were excluded 
from the study. Antiseptic solutions were not used 
before sampling, and the investigator wore gloves for 
sample collection.
Informed owner consent was given for sterile 
single-use swabs (Gima SpA, Gessate, Milano, Italia) 
to be taken from dogs: (a) In case of SBF, two skin 
pustules on the same body region lanced with a 22G 
sterile needle and the pus collected on separate swabs; 
or (b) in case of OE, the external ear canal of right and 
left ear was swabbed at the junction between vertical 
and horizontal canals, for a total of two swabs for each 
ear. In healthy subjects, included as negative controls, 
two sterile swabs were taken from the right external 
ear canal at the junction between vertical and horizon-
tal canals, and two sterile swabs were taken from the 
interdigital skin of a right forepaw.
One of the swabs was analyzed by the veterinary 
microbiology laboratory of the University of Milan 
for aerobic culture, and disk diffusion AST and the 
other immediately tested with Speed Biogram™. The 
following antibiotics, present in Speed Biogram™, 
have been tested with both methods (disk diffusion 
AST and Speed Biogram™): Amoxycillin ( AMO), 
amoxycillin + clavulanic acid (AMC), cephalexin 
(CFL), doxycycline (DOX), enrofloxacin (ENR), 
marbofloxacin (MAR), difloxacin (DIF), clindamycin 
(CLI), gentamycin (GEN), and neomycin (NEO).
Treatment was given to the unhealthy dogs 
included in the study, as indicated by traditional cul-
ture and AST methods.
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Speed Biogram™ test
Briefly, for each test, the following kit was pro-
vided: (i) One disposable culture gallery, (ii) one dis-
posable bottle of preservative medium (ingredients 
not provided by the manufacturer), (iii) one disposable 
bottle of culture medium (ingredients not provided by 
the manufacturer), and (iv) a Staph supplement bottle 
(ingredients not provided by the manufacturer) and a 
bottle of paraffin oil.
The culture gallery included as follows:
• One incubation limit (IL) well that changes color 
from red to orange/yellow if the incubation is 
valid and determines the time of control and anti-
biotic wells reading;
• Two control wells: A bacterial growth control 
well that changes color in the presence of bacte-
rial concentrations >103 CFU/mL and a negative 
control well that must remain colorless during the 
reading of the test.
• Six wells for the identification of pathogenic bac-
teria (bacteria with concentrations >103 CFU/mL) 
(Tables-1 and 2) well for the identification of 
Malassezia spp. and Candida spp. yeasts.
• Thirteen antibiotics wells enabling the determi-
nation of AST of the pathogens present in the 
sample: AMO, AMC, CFL, DOX, ENR, MAR, 
DIF, FLU, CLI, SPI, GEN, NEO, and PXB. The 
method used to test the antimicrobial susceptibil-
ity is not reported by the manufacturer.
Immediately after sampling, the swab was 
placed in the bottle of preservative medium and vigor-
ously shaken, pressed, and rotated against the walls of 
the bottle for few seconds to allow the material from 
the swab to transfer to the medium. After removing 
the swab, the bottle of the preservative medium was 
closed and shaken to mix the contents.
Using a disposable pipette, 3 drops of culture 
medium were transferred to the IL well. With a new 
disposable pipette, 4 drops of the seeded preservative 
medium were placed into the bottle of culture medium. 
The bottle of culture medium was closed and shaken.
Using another disposable pipette, 3 drops of the 
inoculated culture medium were distributed into each 
well of the gallery, with the exception of the IL well. In 
the Staphylococcus identification well (STAPH well), 2 
drops of Staph supplement were added. Then 2 drops of 
paraffin oil were added to each well, with the exception 
of the wells identified as PSEUDO and E. coli wells.
Finally, the gallery was immediately incubated 
at +37°C in a dedicated incubator, not provided by the 
manufacturer.
The correct method of interpretation for Speed 
Biogram™ results is summarized in Figure-1.
Antibiotic wells were interpreted only if the 
negative control well remained colorless, and red col-
oration was observed in the bacterial growth control 
well (Figure-2).
Each bacterial identification well was read 
assessing the color change (Figure-2). Table-1 shows 
the reported color changes for each bacterial well for 
different bacterial species – note multiple microorgan-
isms may be present simultaneously.
As indicated by the manufacture if an identifi-
cation well turned an intermediate color (often asso-
ciated with turbid medium) after 48 h of incubation 
at +37°C (e.g., STAPH well turns from red to turbid 
orange), the well was re-examined 24 h later (at 72 h 
after inoculation), and bacterial identification was 
confirmed only if complete color change appeared. If 
the intermediate color persisted, the bacterial identifi-
cation was considered negative.
To establish the repeatability of Speed Biogram™, 
one bacterial positive and one negative to standard 
culture method sample were analyzed 5 times on the 
same day.
Conservability was tested by performing the 
Speed Biogram™ test on two samples (negative and 
positive to standard culture method), inoculated in the 
preservative medium, cultured on the day of sampling 
and after 24 and 48 h of storage at +4°C, as indicated 
by the manufacturer.
Conventional laboratory culture and AST methods
The strains used in this study were isolated as 
the unique or prevalent bacterial isolate from canine 
skin and/or external ear samples submitted for micro-
biological examination to Veterinary Microbiology 
Laboratory of University of Milan. Bacterial isolation 
was performed through cultivation on Tryptic Soy 
Agar plates containing 5% sheep blood (Microbiol, 
Cagliari, Italy) for 24 h at 37°C under aerobic con-
ditions. Isolates were identified by morphology, 
hemolytic activity (i.e., for Streptococcus), Gram 
stain, catalase activity, and growth on mannitol salt 
agar selective medium and a commercial identifica-
tion kit (API® Staph, BioMériéux, France) was used 
for staphylococci identification; Pseudomonas aeru-
ginosa was identified using Cetrimide agar (Thermo 
Fisher Diagnostics SpA., Milano, Italy) and P. mirabi-
lis by observing typical swarming activity. The strains 
were tested for susceptibility to several antimicro-
bials (AMO, AMC, CFL, DOX, ENR, MAR, DIF, 
CLI, GEN, NEO, oxacillin, and others not present 
in Speed Biogram™) by the disk diffusion method 
(Kirby–Bauer tests) as follows. A 0.5 McFarland 
standardized suspension of each bacterial isolate 
was swabbed over the surface of a Mueller-Hinton 
agar plate (Thermo Fisher Diagnostics SpA., Milano, 
Italy) and paper disks (Thermo Fisher Diagnostics 
SpA., Milano, Italy) containing the different antibiot-
ics (different µg per disk for each kind of molecules) 
were placed onto the inoculated surface. After over-
night incubation at 37°C, the diameters of the zones 
produced by antimicrobial inhibition of bacterial 
growth were measured, and the result was interpreted 
as susceptible, intermediate, or resistant accord-
ing to the criteria recommended by the Clinical and 
Laboratory Standards Institute [23]. Due to technical 
reasons flumequine, spiramycin, and PXB were not 
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tested with standard method because the breakpoints 
were not recognized and available for disk diffusion.
For the isolation of yeasts, the samples were 
swabbed onto Sabouraud Dextrose Agar plates (Oxoid, 
Italy) and incubated for 72 h (or more until 5 days) 
at 25°C. The identification of M. pachydermatis was 
performed using Gram stain; the cells had a typical 
bottle shape.
Statistical analysis
All statistical analyses were performed using 
commercial statistical software (MedCalc, v. 15.0.0, 
Mariakerke, Belgium). Descriptive statistics were 
used for demographic variables. Sensitivity (Se), spec-
ificity (Sp), negative predictive value (NPV), and pos-
itive predictive value (PPV) of the Speed Biogram™ 
for isolation and identification of bacteria and yeast 
were calculated using a 2×2 table based on the agree-
ment with the culture conventional method. Se, Sp, 
NPV, and PPV for susceptibility testing were calcu-
lated by a 2×2 table using resistance (R) as a positive 
result and sensitivity (S) as a negative result for Speed 
Biogram™ relative to AST conventional method. 
Data on oxacillin and other antibiotics susceptibility 
Figure-1: Algorithm for interpretation of Speed Biogram™ results.
Figure-2: Detail of one of the sides of the gallery. On the 
left of the image is some antimicrobial susceptibility testing 
wells with red streaks (bacterial resistance), while on the 
right some wells for bacterial identification, with color 
change in the staphylococcus and streptococcus wells.
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obtained with conventional AST method but not 
with Speed Biogram™ were not considered. Data on 
flumequine, spiramycin, and polymyxin B suscepti-
bility obtained with Speed Biogram™ but not with 
conventional AST method were not considered.
The agreement for the positive results between 
the Speed Biogram™ and the conventional culture 
and AST methods was evaluated using unweighted K 
statistic (k) with a 95% confidence interval (CI). The 
level of agreement was scored according to the fol-
lowing guidelines: 0: No better than chance; <0.20: 
Poor agreement; 0.21-0.40: Fair agreement; 0.41-0.60: 
Moderate agreement; 0.61-0.80: Good agreement; and 
0.81-1.00: Very good agreement [24].
The presence of “major error” (ME) and “very 
major error” (VME) in the detection of antibiotic sensi-
bility with Speed Biogram™ was also evaluated. A “major 
error” occurs when the new test indicates resistance in a 
strain that is categorized as susceptible by the reference 
method (i.e., false negative). This error reduces the range 
of antimicrobial options available to the clinician and 
may lead to unnecessary use of broad-spectrum drugs, 
with potential negative consequences on the selection of 
resistance. A “very major error” occurs when a strain cat-
egorized as resistant by the reference method is reported 
as susceptible by the test (i.e., false positive). This type 
of error has a greater impact on patient care, since the cli-
nician may choose a drug that is unlikely to be effective 
against the strain causing infection, with all the negative 
consequences of treatment failure [25]. The acceptable 
inter method error rates of VME and ME are ≤1.5% and 
≤3%, respectively [26].
Results
A total of 34 canine samples from privately 
owned dogs were included and analyzed: Eleven sam-
ples (32%) from SBF, seven samples (21%) from bac-
terial OE, four samples (12%) from mixed OE, and six 
samples (18%) from Malassezia spp. OE was included, 
while three auricular and three skin samples (18%) were 
taken in six healthy dogs for use as negative controls. In 
mixed and Malassezia spp. OE, an average of 30 yeast 
per microscopic high power field (400×) was detected.
Using a conventional culture method, 18/34 (53%) 
samples were only bacterial culture-positive, 
6/34 (18%) only Malassezia spp. culture-positive, 
4/34 (12%) bacterial and Malassezia spp. culture-pos-
itive, and 6/34 (18%) bacterial and Malassezia spp. 
culture-negative. The same results were obtained with 
Speed Biogram™. The Se and Sp of Speed Biogram™ in 
discriminating between negative and positive samples 
were 100% (95% CI 87.66-100.00) and 100% (95% 
CI 54.07-100.00), respectively (NPV 100%, and PPV 
100%). Unweighted k statistics demonstrated a k value 
of 1 (95% CI 1-1) with a very good agreement in the 
assessment of Malassezia spp. and bacterial infections 
between Speed Biogram™ and conventional culture 
method.
The conventional culture method of 22/34 bacte-
rial positive samples resulted in the growth of S. pseud-
intermedius (n=15), P. aeruginosa (n=7), P. mirabilis 
(n=8), and Streptococcus spp. (n=2), alone or concur-
rent mixed infection.
Speed Biogram™ of the same 22/34 bacte-
rial positive samples resulted in the growth of 
Staphylococcus spp. (n=16), Pseudomonas spp. (n=8), 
Proteus spp. (n=11), Streptococcus spp. (n=7), and E. 
coli (n=2), alone or concurrent mixed infection.
A lack of concordance between the two methods 
was found in eight bacterial positive samples in which 
Speed Biogram™ always not only detected the bacte-
rium identified by the conventional culture method 
but also detected the presence of other associated bac-
teria (Table-2).
The Speed Biogram Enterobacteriaceae family 
well, which changes color in the presence of the genus 
Proteus spp. and/or E. coli, only reacted in 7/13 cases.
Unweighted k statistics demonstrated a k value 
of 0.532 (95% CI 0.319-0.745) for bacterial identi-
fication suggesting a moderate agreement between 
Speed Biogram™ and conventional culture method. 
Single or multiple false antimicrobial susceptibilities 
or resistances with Speed Biogram™ were seen in 
12/22 (55%) bacterial culture-positive samples giving 
a total of 27 discrepancies. Specifically, in 19/27 cases 
(70%) Speed Biogram™ found susceptibility to antibi-
otics in bacteria that were shown to be resistant to that 
antibiotic with the conventional AST method (VME), 
while in the remaining 8/27 (30%) it showed antibi-
otic resistance in bacterial strains that were shown to 
be sensitive using the conventional AST method (ME) 
(Table-3). These errors occurred in different bacterial 
isolations and involved several categories of antibiot-
ics. The sensitivity and specificity of Speed Biogram™ 
for susceptibility testing results were 81.73% (95% 
CI 72.95-88.63) and 93.10% (95% CI 88.86-96.98), 
Table-1: Color changes for each bacterial well in case of positive identification (manufacturer’s instruction).
Name of well Bacteria isolated Initial well color Final well color (positive identification)
STAPH Staphylococcus spp. Red Yellow
STREP Streptococcus spp. Colorless Grey-blue
ENTEROBACT Enterobacteriaceae family Red Yellow/orange
PSEUDO Pseudomonas spp. Colorless Navy blue
E. COLI Escherichia coli Colorless Navy blue ring on the surface of well with 
contemporaneous change of color of ENTEROBACT well
PROTEUS Proteus spp. Yellow/orange purplish pink with contemporaneous change of color of 
ENTEROBACT well
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respectively (NPV 85%, and PPV 91.4%). Unweighted 
k statistics demonstrated a good or very good agree-
ment between Speed Biogram and conventional AST 
for tested antibiotics (average k=0.714) except for 
ENR, for which a moderate agreement (k=0.54 95% 
CI 0.184-0.892) was detected (Table-3).
The repeatability of the Speed Biogram™ was 
very good. The same results were recorded for cul-
ture and antimicrobial susceptibility in all five tests 
repeated on a singular positive and negative sample. 
The Speed Biogram™ also returned the same results 
in tests performed after 24 and 48 h storage periods.
Discussion
Rational antimicrobial use is a key element 
for control of antimicrobial resistance, especially 
in veterinary dermatology. There is a European and 
global drive to reduce antimicrobial use in animals, 
including companion animals [6]. Selection of appro-
priate antimicrobials for treatment of SBF and OE is 
aided by rapid and reliable PoC tests to ensure that 
(i) antimicrobials are prescribed/used only when nec-
essary, and (ii) the most appropriate drug is chosen 
based on antimicrobial resistance profiles [25].
To the best of our knowledge, this is the first 
attempt to determine the performance of a PoC test 
for yeast and bacteria identification and AST in vet-
erinary dermatology. Our results show that Speed 
Biogram™ is easy to read and gives repeatable results. 
Our study also confirmed that the inoculated preser-
vative medium remains stable for 48 h at +4°C, which 
is beneficial in clinical practice if sample processing 
is delayed. However, an incubator is required for the 
execution of Speed Biogram™ test, and the absence 
of this tool may limit the use of this PoC test in clini-
cal settings.
Speed Biogram™ produces excellent results for 
the detection of bacterial and yeast infections in dogs. 
Its ability to discriminate healthy from pathological 
samples showed very good agreement with the con-
ventional culture method, which is important to avoid 
the improper use of antibiotics in patients where there 
is no bacterial infection.
The disadvantage of Speed Biogram™ is the incu-
bation time required before reading the result (48 h for 
bacteria and up to 72 h for Malassezia spp.). Although 
this is similar to that of conventional culture [27], it is 
much longer than the cytological examination, which 
Table-2: Culture-positive samples with conventional culture and Speed Biogram™.
Origin Conventional culture method Speed Biogram™
OE Pseudomonas aeruginosa Pseudomonas spp.
OE Proteus mirabilis Proteus spp., Enterobacteriaceae
OE Staphylococcus pseudintermedius, Proteus mirabilis Staphylococcus spp., Proteus spp.
OE Proteus mirabilis, Pseudomonas aeruginosa Staphylococcus spp., Proteus spp., Pseudomonas spp., 
Streptococcus spp., Enterobacteriaceae
OE Staphylococcus pseudintermedius, Malassezia 
pachydermatis
Staphylococcus spp., Malassezia spp.
SBF Staphylococcus pseudintermedius, Proteus mirabilis Staphylococcus spp., Proteus spp., Enterobacteriaceae
SBF Pseudomonas aeruginosa Pseudomonas spp.
SBF Staphylococcus pseudintermedius, Pseudomonas 
aeruginosa
Staphylococcus spp., Pseudomonas spp., Proteus spp.
OE Staphylococcus pseudintermedius, Streptococcus spp. Staphylococcus spp., Streptococcus spp.
SBF Staphylococcus pseudintermedius, Pseudomonas 
aeruginosa, Proteus mirabilis
Staphylococcus spp., Proteus spp., Pseudomonas spp., 
Streptococcus spp., Enterobacteriaceae, Escherichia coli
SBF Staphylococcus pseudintermedius Staphylococcus spp.
OE Streptococcus spp. Streptococcus spp.
SBF Staphylococcus pseudintermedius Staphylococcus spp.
OE Staphylococcus pseudintermedius, Malassezia 
pachydermatis
Staphylococcus spp., Streptococcus spp., Malassezia spp.
SBF Staphylococcus pseudintermedius, Pseudomonas 
aeruginosa
Staphylococcus spp., Proteus spp., Pseudomonas spp.
SBF Staphylococcus pseudintermedius, Proteus mirabilis Staphylococcus spp., Proteus spp., Pseudomonas spp.
OE Proteus mirabilis, Malassezia pachydermatis Proteus spp., Malassezia spp., Enterobacteriaceae
SBF Staphylococcus pseudintermedius Staphylococcus spp.
SBF Staphylococcus pseudintermedius, Pseudomonas 
aeruginosa, Proteus mirabilis
Staphylococcus spp., Proteus spp., Pseudomonas spp., 
Streptococcus spp., Enterobacteriaceae, Escherichia coli
OE Staphylococcus pseudintermedius, Malassezia 
pachydermatis
Staphylococcus spp., Streptococcus spp., Malassezia spp.
SBF Staphylococcus pseudintermedius Staphylococcus spp.
OE Proteus mirabilis Proteus spp., Enterobacteriaceae
OE Malassezia pachydermatis Malassezia spp.
OE Malassezia pachydermatis Malassezia spp.
OE Malassezia pachydermatis Malassezia spp.
OE Malassezia pachydermatis Malassezia spp.
OE Malassezia pachydermatis Malassezia spp.
OE Malassezia pachydermatis Malassezia spp.
SBF=Superficial bacterial folliculitis, OE=Otitis externa
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requires only a stained slide prepared in a few min-
utes. The long incubation times of the Speed Biogram™ 
are a disadvantage, especially in the case of a simple 
Malassezia spp. OE, as the test does not give results 
until 2-3 days after inoculation and provides no details 
of the amount of yeast detected, or about drug resis-
tance. However, cytological interpretation of skin or 
ear slide requires a trained operator and a good cyto-
logical technique [28], while the Speed Biogram™ 
results are very easy to interpret for first-time users 
with no other equipment (i.e., optical microscope).
In our study, the most commonly isolated bac-
teria were Staphylococcus spp., Pseudomonas spp., 
and Proteus spp., as in the previous literature data [1]. 
Although Speed Biogram™ identifies bacteria only to 
genus level, except for E. coli, this difference is not 
of great significance in clinical practice, where genus 
identification with appropriate AST may be sufficient 
to establish adequate antibiotic therapy. This is not true 
for some bacterial species, including Staphylococcus 
spp., because S. aureus and S. pseudintermedius have 
different susceptibility breakpoint with regard to the 
most important drug (oxacillin), not evaluated by 
Speed Biogram™. Speed Biogram™ does not allow 
determination of coagulase status of staphylococci and 
this could lead to the erroneous identification of coag-
ulase-negative staphylococci, which normally have no 
pathogenic significance, such as S. pseudintermedius.
The moderate agreement with k statistics in bac-
terial identification between Speed Biogram™and con-
ventional culture is due to differences in eight bacterial 
positive samples in which Speed Biogram™ identified 
the bacteria cultured by the conventional culture method 
but in combination with other bacteria. The unreliabil-
ity of these additional isolations is supported by the fact 
that in many identifications of Proteus spp. with the 
Speed Biogram™, the Enterobacteriaceae well, which 
should have been simultaneously colored, remained 
colorless. The presence of multiple identifications can 
be due to a poorly standardized inoculum and to the fact 
that the culture cannot be purified. Polymicrobial cul-
tures are common in otitis and can occur from skin sam-
ples. In these cases, the relevance of the culture result 
and the selection of the isolate for AST need to be deter-
mined. The current recommendation for human wound 
infections is that the growth of potential pathogens 
should be reported, preferably semi-quantitatively and 
AST should be performed when a pathogen is isolated 
in pure culture or in abundance with minimal involve-
ment of other micro-organisms [6]. Antimicrobial 
therapy should target microorganism with the great-
est pathogenic potential. Indiscriminate reporting of 
AST profiles for microorganisms of minimal clinical 
relevance is discouraged to avoid unnecessary use of 
broad-spectrum antimicrobial drugs to cover the com-
posite AST profiles of multiple isolates [17]. The poly-
microbial inoculum highlighted with Speed Biogram™ 
may adversely affect susceptibility testing, which is 
based on the inoculation of the same culture medium.
Speed Biogram™ showed a mean good concor-
dance on k statistics with conventional AST for nine 
tested antibiotics and moderate for ENR. This lesser 
Table-3: Antimicrobial susceptibilities or resistances with Speed Biogram™.
SAMPLE NUMBER AMO AMC CFL DOX ENR MAR DIF FLU CLI SPI GEN PXB NEO
1. R R R R R R R R R R S S S
2. S S S S S S R R S S S R R
3. S S S R S R S R R R S R R
4. R R R R R R R R R R R R R
5. S S S S S S S S S S S S S
6. S S S S S S S S S S S S S
7. S S S S S S R R S S S R R
8. R R R R R R R R R R R R S
9. S S R S R R R R R R R R R
10. R R S S R R R S R R R S S
11. S S S R S S S R R R S R R
12. S S S R S S S R S S S S S
13. S S S S S R R R R R R R R
14. S S R R S R R R R R R R R
15. R R R R R R R R R R R R S
16. S S S R S S R R R R S R S
17. S S S S S S S S S S S S S
18. S S S S S S S S S S S S S
19. R R R S R R R R R R R S R
20. R S S S R S R R R R R R R
21. S S S S S S S S S S S S S
22. S S S S S S R R S S S R R
K value 0.718 0.703 0.897 0.690 0.538 0.814 0.904 - 0.611 - 0.812 - 0.727
With white background, the samples totally in agreement with conventional AST. With light grey background, 
the samples are not in agreement with conventional AST. In bold with dark grey background, the single false 
resistances (ME) and susceptibilities (VME). AMO=Amoxycillin, AMC=Amoxycillin + clavulanic acid, CFL=Cefalexin, 
DOX=Doxycycline, ENR=Enrofloxacin, MAR=Marbofloxacin, DIF=Difloxacin, FLU=Flumequine, CLI=Clindamycin, 
SPI=Spiramycin, GEN=Gentamicin, PXB=Polymyxin B, NEO=Neomycin, AST=Antimicrobial susceptibility testing, 
ME=Major error, VME=Very major error
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concordance with ENR is not easily explained, since 
the antibiogram relative to other fluoroquinolones in 
the Speed Biogram™ yielded superior or almost opti-
mal results, as in the case of DIF.
When analyzing individual samples, we found a 
55% chance that the antibiogram of Speed Biogram™ 
is different from that suggested by conventional 
AST, and 70% of this is characterized by false sus-
ceptibility. These “major” or “very major” errors are 
extremely important – the Speed Biogram™ produced 
many “very major errors,” and therefore care must be 
taken in the interpretation of results as false antimi-
crobial susceptibilities may lead to inappropriate ther-
apeutic choices, increasing the possibility of selection 
of MDR bacteria. Speed Biogram™ cannot test for the 
presence of methicillin-resistant S. aureus or methicil-
lin-resistant S. pseudintermedius, as it lacks antibiot-
ics such as oxacillin or cefoxitin [29]; further limiting 
its use, considering the importance of this data in pub-
lic health and veterinary dermatology.
Our study has some limitations: It was not pos-
sible to provide data for flumequine, spiramycin, and 
polymyxin B – although these antibiotics were present 
in the Speed Biogram™, they are not available for disk 
diffusion AST or the breakpoints are not recognized. 
The absence of this data may have affected the statis-
tical evaluation of the study. Another limit is the use of 
Kirby–Bauer disk diffusion test, based on serum level 
concentrations of drugs for AST for the treatment of 
OE, since topical therapy is typically used in most 
cases.
Furthermore, the variable sizes of the evaluation 
groups (dog with SBF, bacterial OE, Malassezia spp. 
OE, mixed OE, and healthy dogs) may have led to an 
overestimation of the sensitivity and specificity of 
Speed Biogram™ in the diagnosis of SBF and OE. In 
particular, ten dogs were enrolled with Malassezia spp. 
or mixed OE (with high cytological yeast numbers on 
microscopical high power field) and only six healthy 
dogs and, although Speed Biogram™ always cor-
rectly identified healthy and diseased subjects, its 
mechanism of identification is not clear, as the manu-
facturer does not provide a yeast growth control well 
with a detection limit for yeast isolation. Another 
possible limitation of our study is that dogs receiving 
antibiotic/antimycotic drugs in the previous 2 weeks 
were excluded. This exclusion criterion was imple-
mented to avoid the administration of antibiotics as 
a confounding factor, but this choice led to the selec-
tion of a limited sample of subjects and did not test 
Speed Biogram™ in real clinical practice where it is 
necessary to perform sensitivity tests while the dog is 
receiving antibiotic or antifungal therapy.
Conclusion
Speed Biogram™ is an easy to use PoC test for 
identifying dogs affected by SBF and OE. However, 
results of yeast identification cannot be interpreted 
for at least 48 h and precise identification of bacterial 
species responsible for the infection was not possible 
due to repeated, incorrect polymicrobial isolations.
Therefore, it can only be used in clinical prac-
tice in association with compatible clinical signs and 
cytological examination of samples. Speed Biogram™ 
may, however, be especially helpful in instances where 
cytological assessment from skin and auricular sites is 
not possible (inadequate equipment and training).
Speed Biogram™ cannot determine individ-
ual susceptibilities in polymicrobial isolations and 
reported several false antibiotic susceptibilities 
(VME). This limitation, along with the ability to iden-
tify bacteria only to the genus and the lack of suscep-
tibility testing for methicillin, make Speed Biogram™ 
inadequate to guide antimicrobial therapy for SBF and 
OE in small animal practice and inappropriate for use 
in clinical dermatologic practice.
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